Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Cancers
|
June 2, 2021
Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor
Dana C Borcherding, Eric R Hugo, Sejal R Fox, et al.
Chembiochem : a European Journal of Chemical Biology
|
October 1, 2015
A ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway Compounds
Fathima Shazna Thowfeik, Safnas F AbdulSalam, Mark Wunderlich, et al.
Chembiochem : a European Journal of Chemical Biology
|
August 16, 2017
Self-Cyclizing Antioxidants to Prevent DNA Damage Caused by Hydroxyl Radical
Safnas F AbdulSalam, Purujit N Gurjar, Haizhou Zhu, et al.
International Journal of Molecular Sciences
|
March 6, 2021
Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (ROS)-Activated Prodrug in Combination with Anthracycline Impairs PI3K Signaling, Increases DNA Damage Response and Reduces Breast Cancer Cell Growth
Rosalin Mishra, Long Yuan, Hima Patel, et al.
Chemmedchem
|
November 8, 2019
Oxidative Cyclization-Induced Activation of a Phosphoinositide 3-Kinase Inhibitor for Enhanced Selectivity of Cancer Chemotherapeutics
Haizhou Zhu, Rosalin Mishra, Long Yuan, et al.
Free Radical Biology & Medicine
|
January 4, 2019
UV cell stress induces oxidative cyclization of a protective reagent for DNA damage reduction in skin explants
Jing Liu, Haizhou Zhu, Gurdat Premnauth, et al.
Journal of Inorganic Biochemistry
|
November 5, 2013
Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release
Kyle T Hufziger, Fathima Shazna Thowfeik, David J Charboneau, et al.
Scientific Reports
|
September 28, 2021
Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
Kaylin G Earnest, Erin M McConnell, Eman M Hassan, et al.
Bioorganic & Medicinal Chemistry
|
March 18, 2015
Base-modified thymidines capable of terminating DNA synthesis are novel bioactive compounds with activity in cancer cells
Kayla M Borland, Safnas F AbdulSalam, Morwena J Solivio, et al.
Journal of the American Chemical Society
|
November 18, 2015
A Redox-Active, Compact Molecule for Cross-Linking Amyloidogenic Peptides into Nontoxic, Off-Pathway Aggregates: In Vitro and In Vivo Efficacy and Molecular Mechanisms
Jeffrey S Derrick, Richard A Kerr, Younwoo Nam, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Cancers
|
June 2, 2021
Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor
Dana C Borcherding, Eric R Hugo, Sejal R Fox, et al.
Chembiochem : a European Journal of Chemical Biology
|
October 1, 2015
A ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway Compounds
Fathima Shazna Thowfeik, Safnas F AbdulSalam, Mark Wunderlich, et al.
Chembiochem : a European Journal of Chemical Biology
|
August 16, 2017
Self-Cyclizing Antioxidants to Prevent DNA Damage Caused by Hydroxyl Radical
Safnas F AbdulSalam, Purujit N Gurjar, Haizhou Zhu, et al.
International Journal of Molecular Sciences
|
March 6, 2021
Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (ROS)-Activated Prodrug in Combination with Anthracycline Impairs PI3K Signaling, Increases DNA Damage Response and Reduces Breast Cancer Cell Growth
Rosalin Mishra, Long Yuan, Hima Patel, et al.
Chemmedchem
|
November 8, 2019
Oxidative Cyclization-Induced Activation of a Phosphoinositide 3-Kinase Inhibitor for Enhanced Selectivity of Cancer Chemotherapeutics
Haizhou Zhu, Rosalin Mishra, Long Yuan, et al.
Free Radical Biology & Medicine
|
January 4, 2019
UV cell stress induces oxidative cyclization of a protective reagent for DNA damage reduction in skin explants
Jing Liu, Haizhou Zhu, Gurdat Premnauth, et al.
Journal of Inorganic Biochemistry
|
November 5, 2013
Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release
Kyle T Hufziger, Fathima Shazna Thowfeik, David J Charboneau, et al.
Scientific Reports
|
September 28, 2021
Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
Kaylin G Earnest, Erin M McConnell, Eman M Hassan, et al.
Bioorganic & Medicinal Chemistry
|
March 18, 2015
Base-modified thymidines capable of terminating DNA synthesis are novel bioactive compounds with activity in cancer cells
Kayla M Borland, Safnas F AbdulSalam, Morwena J Solivio, et al.
Journal of the American Chemical Society
|
November 18, 2015
A Redox-Active, Compact Molecule for Cross-Linking Amyloidogenic Peptides into Nontoxic, Off-Pathway Aggregates: In Vitro and In Vivo Efficacy and Molecular Mechanisms
Jeffrey S Derrick, Richard A Kerr, Younwoo Nam, et al.
Page
of 5